Literature DB >> 18487610

Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens.

Camilla Giudici1, Nicolas Raynal, Hanna Wiedemann, Wayne A Cabral, Joan C Marini, Rupert Timpl, Hans Peter Bächinger, Richard W Farndale, Takako Sasaki, Ruggero Tenni.   

Abstract

The 33-kDa matrix protein SPARC (BM-40, osteonectin) binds several collagen types with moderate affinity. The collagen-binding site resides in helix alphaA of the extracellular calcium-binding domain of SPARC and is partially masked by helix alphaC. Previously, we found that the removal of helix alphaC caused a 10-fold increase in the affinity of SPARC for collagen, and we identified amino acids crucial for binding by site-directed mutagenesis. In this study, we used rotary shadowing, CNBr peptides, and synthetic peptides to map binding sites of SPARC onto collagens I, II, and III. Rotary shadowing and electron microscopy of SPARC-collagen complexes identified a major binding site approximately 180 nm from the C terminus of collagen. SPARC binding was also detected with lower frequency near the matrix metalloproteinase cleavage site. These data fit well with our analysis of SPARC binding to CNBr peptides, denaturation of which abolished binding, indicating triple-helical conformation of collagen to be essential. SPARC binding was substantially decreased in two of seven alpha2(I) mutant procollagen I samples and after N-acetylation of Lys/Hyl side chains in wild-type collagen. Synthetic peptides of collagen III were used to locate the binding sites, and we found SPARC binding activity in a synthetic triple-helical peptide containing the sequence GPOGPSGPRGQOGVMGFOGPKGNDGAO (where O indicates 4-hydroxyproline), with affinity for SPARC comparable with that of procollagen III. This sequence is conserved among alpha chains of collagens I, II, III, and V. In vitro collagen fibrillogenesis was delayed in the presence of SPARC, suggesting that SPARC might modulate collagen fibril assembly in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18487610      PMCID: PMC2443679          DOI: 10.1074/jbc.M710001200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Matricellular hevin regulates decorin production and collagen assembly.

Authors:  Millicent M Sullivan; Thomas H Barker; Sarah E Funk; Ari Karchin; Neung S Seo; Magnus Höök; Joan Sanders; Barry Starcher; Thomas N Wight; Pauli Puolakkainen; E Helene Sage
Journal:  J Biol Chem       Date:  2006-07-14       Impact factor: 5.157

2.  Structural basis of the collagen-binding mode of discoidin domain receptor 2.

Authors:  Osamu Ichikawa; Masanori Osawa; Noritaka Nishida; Naoki Goshima; Nobuo Nomura; Ichio Shimada
Journal:  EMBO J       Date:  2007-08-16       Impact factor: 11.598

3.  A substitution of cysteine for glycine 748 of the alpha 1 chain produces a kink at this site in the procollagen I molecule and an altered N-proteinase cleavage site over 225 nm away.

Authors:  B E Vogel; R Doelz; K E Kadler; Y Hojima; J Engel; D J Prockop
Journal:  J Biol Chem       Date:  1988-12-15       Impact factor: 5.157

Review 4.  Mammalian collagen receptors.

Authors:  Birgit Leitinger; Erhard Hohenester
Journal:  Matrix Biol       Date:  2006-11-10       Impact factor: 11.583

5.  Collagen XXVIII, a novel von Willebrand factor A domain-containing protein with many imperfections in the collagenous domain.

Authors:  Guido Veit; Birgit Kobbe; Douglas R Keene; Mats Paulsson; Manuel Koch; Raimund Wagener
Journal:  J Biol Chem       Date:  2005-12-05       Impact factor: 5.157

6.  Molecular cloning of SC1: a putative brain extracellular matrix glycoprotein showing partial similarity to osteonectin/BM40/SPARC.

Authors:  I G Johnston; T Paladino; J W Gurd; I R Brown
Journal:  Neuron       Date:  1990-01       Impact factor: 17.173

7.  Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VI.

Authors:  Katsunori Horii; Mark L Kahn; Andrew B Herr
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

Review 8.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.

Authors:  Joan C Marini; Antonella Forlino; Wayne A Cabral; Aileen M Barnes; James D San Antonio; Sarah Milgrom; James C Hyland; Jarmo Körkkö; Darwin J Prockop; Anne De Paepe; Paul Coucke; Sofie Symoens; Francis H Glorieux; Peter J Roughley; Alan M Lund; Kaija Kuurila-Svahn; Heini Hartikka; Daniel H Cohn; Deborah Krakow; Monica Mottes; Ulrike Schwarze; Diana Chen; Kathleen Yang; Christine Kuslich; James Troendle; Raymond Dalgleish; Peter H Byers
Journal:  Hum Mutat       Date:  2007-03       Impact factor: 4.878

9.  SPARC regulates processing of procollagen I and collagen fibrillogenesis in dermal fibroblasts.

Authors:  Tyler J Rentz; Felicitta Poobalarahi; Paul Bornstein; E Helene Sage; Amy D Bradshaw
Journal:  J Biol Chem       Date:  2007-05-23       Impact factor: 5.157

10.  A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides.

Authors:  Ton Lisman; Nicolas Raynal; Dafna Groeneveld; Ben Maddox; Anthony R Peachey; Eric G Huizinga; Philip G de Groot; Richard W Farndale
Journal:  Blood       Date:  2006-08-15       Impact factor: 22.113

View more
  46 in total

1.  Implications for collagen I chain registry from the structure of the collagen von Willebrand factor A3 domain complex.

Authors:  T Harma C Brondijk; Dominique Bihan; Richard W Farndale; Eric G Huizinga
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-21       Impact factor: 11.205

2.  Proteome of Rhipicephalus sanguineus tick saliva induced by the secretagogues pilocarpine and dopamine.

Authors:  C J Oliveira; E Anatriello; I K de Miranda-Santos; I M Francischetti; A Sá-Nunes; B R Ferreira; J M C Ribeiro
Journal:  Ticks Tick Borne Dis       Date:  2013-09-09       Impact factor: 3.744

Review 3.  Structural insights into the interactions between platelet receptors and fibrillar collagen.

Authors:  Andrew B Herr; Richard W Farndale
Journal:  J Biol Chem       Date:  2009-04-28       Impact factor: 5.157

4.  Aegyptin displays high-affinity for the von Willebrand factor binding site (RGQOGVMGF) in collagen and inhibits carotid thrombus formation in vivo.

Authors:  Eric Calvo; Fuyuki Tokumasu; Daniella M Mizurini; Peter McPhie; David L Narum; José Marcos C Ribeiro; Robson Q Monteiro; Ivo M B Francischetti
Journal:  FEBS J       Date:  2009-12-15       Impact factor: 5.542

5.  The NC2 domain of type IX collagen determines the chain register of the triple helix.

Authors:  Sergei P Boudko; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2012-11-06       Impact factor: 5.157

Review 6.  Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling.

Authors:  Hsueh-Liang Fu; Rajeshwari R Valiathan; Richard Arkwright; Anjum Sohail; Cosmin Mihai; Malika Kumarasiri; Kiran V Mahasenan; Shahriar Mobashery; Paul Huang; Gunjan Agarwal; Rafael Fridman
Journal:  J Biol Chem       Date:  2013-01-18       Impact factor: 5.157

Review 7.  Diverse biological functions of the SPARC family of proteins.

Authors:  Amy D Bradshaw
Journal:  Int J Biochem Cell Biol       Date:  2012-01-09       Impact factor: 5.085

Review 8.  Using proteomics to uncover extracellular matrix interactions during cardiac remodeling.

Authors:  Nicolle L Patterson; Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás; Yaojun Li; Thomas G Andrews; Gregory J Aune; Richard A Lange; Merry L Lindsey
Journal:  Proteomics Clin Appl       Date:  2013-07-08       Impact factor: 3.494

9.  The role of SPARC in extracellular matrix assembly.

Authors:  Amy D Bradshaw
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

10.  Crystallographic insight into collagen recognition by discoidin domain receptor 2.

Authors:  Federico Carafoli; Dominique Bihan; Stavros Stathopoulos; Antonios D Konitsiotis; Marc Kvansakul; Richard W Farndale; Birgit Leitinger; Erhard Hohenester
Journal:  Structure       Date:  2009-12-09       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.